Top

Reactions Weekly

Published in:

01-02-2023 | Anakinra | Case report

Anakinra/corticosteroids/immune globulin

No response: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Gornicec M, et al. Sustained complete remission with Ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis: a case report. Oncology Research and Treatment 42 (Suppl. 4): 183, Oct 2019. Available from: URL: http://doi.org/10.1159/000502425 [abstract]

Title: Anakinra/corticosteroids/immune globulin
No response: case report
Publication date: 01-02-2023
Publisher: Springer International Publishing
Keywords: Anakinra
Leukopenia
Maintenance Therapy
Hemophagocytic Lymphohistiocytosis
Ruxolitinib
Hemophagocytic Lymphohistiocytosis
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-33575-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Anakinra/corticosteroids/immune globulin

No response: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Elasomeran/tozinameran

Temozolomide

Enoxaparin sodium

Pembrolizumab

Amphotericin-B-liposomal

Multiple drugs